Development and Validation of Prediction Models for Subtype Diagnosis of Patients With Primary Aldosteronism.
Adrenal Cortex Function Tests
Adrenal Glands
/ diagnostic imaging
Adrenalectomy
Adult
Aldosterone
/ blood
Clinical Decision-Making
/ methods
Decision Support Techniques
Female
Humans
Hyperaldosteronism
/ blood
Male
Middle Aged
Potassium
/ blood
ROC Curve
Regression Analysis
Retrospective Studies
Supervised Machine Learning
Tomography, X-Ray Computed
adrenal venous sampling
aldosterone
machine learning
primary aldosteronism
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
22
03
2020
accepted:
11
06
2020
pubmed:
21
6
2020
medline:
20
2
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
Primary aldosteronism (PA) comprises unilateral (lateralized [LPA]) and bilateral disease (BPA). The identification of LPA is important to recommend potentially curative adrenalectomy. Adrenal venous sampling (AVS) is considered the gold standard for PA subtyping, but the procedure is available in few referral centers. To develop prediction models for subtype diagnosis of PA using patient clinical and biochemical characteristics. Patients referred to a tertiary hypertension unit. Diagnostic algorithms were built and tested in a training (N = 150) and in an internal validation cohort (N = 65), respectively. The models were validated in an external independent cohort (N = 118). Regression analyses and supervised machine learning algorithms were used to develop and validate 2 diagnostic models and a 20-point score to classify patients with PA according to subtype diagnosis. Six parameters were associated with a diagnosis of LPA (aldosterone at screening and after confirmatory testing, lowest potassium value, presence/absence of nodules, nodule diameter, and computed tomography results) and were included in the diagnostic models. Machine learning algorithms displayed high accuracy at training and internal validation (79.1%-93%), whereas a 20-point score reached an area under the curve of 0.896, and a sensitivity/specificity of 91.7/79.3%. An integrated flowchart correctly addressed 96.3% of patients to surgery and would have avoided AVS in 43.7% of patients. The external validation on an independent cohort confirmed a similar diagnostic performance. Diagnostic modelling techniques can be used for subtype diagnosis and guide surgical decision in patients with PA in centers where AVS is unavailable.
Identifiants
pubmed: 32561919
pii: 5860167
doi: 10.1210/clinem/dgaa379
pii:
doi:
Substances chimiques
Aldosterone
4964P6T9RB
Potassium
RWP5GA015D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.